The short answer: GLP-1 medications don't directly increase or replace estrogen, progesterone, or other reproductive hormones
FDA, 4:25-cv-00174) challenging the FDAs decision to remove semaglutide from the drug shortage list
Swelling beyond the injection site, widespread hives, or breathing changes stop, antihistamine, ER if needed
use requires informed consent and professional medical oversight to monitor for efficacy and safety
A phase II randomized placebo-controlled trial
These effects are closely related to the activation of GLP-1 receptors in both central and peripheral pathways, often leading to reduced treatment adherence or even discontinuation, which can compromise therapeutic outcomes ( Bayesian network meta-analysis offers a solution to this limitation by enabling the simultaneous comparison of multiple treatment options, providing a more precise evaluation of the differences between drugs ( 2 Materials and methods This study was designed and conducted according to the registration requirements of the PROSPERO database (CRD42024592308) and aims to systematically evaluate the gastrointestinal adverse effects of different GLP-1 receptor agonists (GLP-1RAs) in patients with type 2 diabetes mellitus (T2DM)
